Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.745 USD | +8.93% | +44.59% | -9.61% |
03:04pm | HC Wainwright Adjusts Price Target on Replimune to $17 From $12, Maintains Buy Rating | MT |
06-06 | Sector Update: Health Care Stocks Higher in Late Afternoon Trading | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.61% | 437M | |
+50.91% | 59.28B | |
+41.42% | 40.94B | |
-5.40% | 40.17B | |
-5.16% | 28.69B | |
+12.98% | 26.63B | |
-20.33% | 18.89B | |
+31.44% | 12.46B | |
+0.38% | 12.42B | |
+26.13% | 12.26B |
- Stock Market
- Equities
- REPL Stock
- News Replimune Group, Inc.
- Replimune Group's Fiscal Q4 Net Loss Widens